Quantum Surgical SAS

Quantum Surgical is a French medical robotics and AI company founded in 2017, specializing in robotic-assisted interventional oncology. Headquartered in Montpellier with a Miami office, the company develops and markets the Epione® robotic platform—a CE-marked and FDA 510(k)-cleared system designed for percutaneous tumor ablation in abdominal, chest, and musculoskeletal lesions. Epione integrates planning, navigation, targeting, and ablation confirmation into a single workflow, enabling minimally invasive treatment of early-stage and challenging tumors that are difficult to reach or surgically inaccessible. The platform has treated over 1,500 patients at 20+ cancer centers in Europe and North America. The Epione system standardizes access to ablation therapy, reducing procedural complexity while improving patient safety, reducing recovery time, and enabling outpatient procedures. Quantum Surgical also acquired NeuWave Medical, expanding its portfolio in thermal ablation technologies. With 130+ employees and recognition including the 2022 Prix Galien USA award, the company continues expanding market approvals and clinical installations.